9HJZ

Crystal structure of human geranylgeranyl diphosphate synthase mutant Y246D

Summary for 9HJZ

• Entry DOI: 10.2210/pdb9hjz/pdb
• Descriptor: Geranylgeranyl pyrophosphate synthase, CITRIC ACID (3 entities in total)
• Functional Keywords: geranylgeranyl diphosphate, dimer, prenyltransferase, transferase
• Biological source: Homo sapiens (human)
• Total number of polymer chains: 2
• Total formula weight: 70968.51

Authors

Yehia, R.,Giladi, M.,Haitin, Y. (deposition date: 2024-12-02, release date: 2025-06-25, Last modification date: 2025-12-10)

Primary citation

Yehia, R.,Portasikova, J.M.,Mor Yosef, R.,Da'adoosh, B.,Kadek, A.,Man, P.,Giladi, M.,Haitin, Y.
A somatic multiple myeloma mutation unravels a mechanism of oligomerization-mediated product inhibition in GGPPS.
Febs J., 292:5802-5817, 2025

PubMed Abstract: Protein prenylation plays a critical role in regulating the cellular localization of small GTPases and is essential for multiple myeloma (MM) pathology. Geranylgeranyl diphosphate synthase (GGPPS), producing a key prenylation moiety, exists in a dimeric or hexameric form, depending on the species. However, the functional significance of this oligomerization remains unclear. Using crystallography, mass spectrometry, and fluorescence spectroscopy, we show that the GGPPS mutant-found in the widely studied MM cell line RPMI-8226-exhibits weakened inter-dimer interactions, reduced hexamer stability, and increased apparent substrate affinity and product release kinetics. These effects are even more pronounced in a dimeric mutant, GGPPS, demonstrating that interdimer interactions within the hexamer help stabilize a lid region over the active site, thereby stabilizing product binding in an inhibitory conformation. Together, these findings reveal that hexamerization regulates GGPPS activity through product inhibition and underscore the importance of cell line selection and characterization in drug discovery efforts.

PubMed: 40621901
DOI: 10.1111/febs.70181

Experimental method

X-RAY DIFFRACTION (2.54 Å)